Sabin Vaccine Institute Receives $35 Million from BARDA with Potential of Up to $214 Million for Ebola Sudan and Marburg Vaccines
WASHINGTON, Jan. 12 (Korea Bizwire) — The Sabin Vaccine Institute today announced that the Biomedical Advanced Research and Development Authority (BARDA) has awarded Sabin a multi-year contract with funding potential for up to $214 million to advance the development and production of single-dose vaccine candidates for Ebola Sudan and Marburg virus diseases. There are currently [...]